Cd treatment stimulates breast cancer cell proliferation by activating ER-α–dependent Akt (protein kinase B), Erk1/2 (extracellular signal-regulated kinase), and platelet-derived growth factor receptor-α (Brama et al. 2007). Here, AKT1 is linked to breast cancer.